Emerald Advisers »

Keros Therapeutics shares owned by Emerald Advisers

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Emerald Advisers from 13F filings

Historical chart of Emerald Advisers investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Emerald Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.0M 156k 58.07